Dr Lal PathLabs to acquire 70% stake in genomics firm SN Genelab for up to ₹168 crore

Shares of Dr Lal PathLabs Ltd ended at ₹1,958.80, up by ₹36.20, or 1.88%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *